Rankings for Scientist

University, Subject, Country, Region, World

Eli Lilly and Company Scientists Rankings 2024

Country

Total 190 scientist, 1 country, 1 institution

List without CERN, Statistical Data etc.

Sort by last 6 years H Index

David A Collier ⁱ

Best Scientist in University/Institution

Eli Lilly and Company

United States

Social Sciences / Psychology

psychosis

neurodegeneration

bioinformatics

genomics

drug development

H-Index Rankings

University / Institution:

# 1

Country:

# 1,804

Region:

# 1,940

World:

# 3,860

H-Index

Total:

122

Last 6 Year:

Last 6 Year/Total:

0.508

i10 Index

Total:

436

Last 6 Year:

247

Last 6 Year/Total:

0.567

Citation

Total:

80,727

Last 6 Year:

27,588

Last 6 Year/Total:

0.342

Stephen Hall

Eli Lilly and Company

United States

Others

PBPK Models

DDI

CYPs

H-Index Rankings

University / Institution:

# 2

Country:

# 9,841

Region:

# 10,820

World:

# 22,504

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.474

i10 Index

Total:

174

Last 6 Year:

105

Last 6 Year/Total:

0.603

Citation

Total:

22,555

Last 6 Year:

4,677

Last 6 Year/Total:

0.207

Christian C Felder

Eli Lilly and Company

United States

Medical and Health Sciences / Neuroscience

Neuroscience & Drug Discovery

H-Index Rankings

University / Institution:

# 3

Country:

# 10,275

Region:

# 11,296

World:

# 23,566

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.440

i10 Index

Total:

141

Last 6 Year:

Last 6 Year/Total:

0.610

Citation

Total:

24,931

Last 6 Year:

4,992

Last 6 Year/Total:

0.200

David R Ferry

Eli Lilly and Company

United States

Others

GI cancer

translational research

lung cancer

phase 1 trials

H-Index Rankings

University / Institution:

# 4

Country:

# 11,020

Region:

# 12,132

World:

# 25,527

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.548

i10 Index

Total:

175

Last 6 Year:

Last 6 Year/Total:

0.480

Citation

Total:

26,276

Last 6 Year:

8,585

Last 6 Year/Total:

0.327

Jiye Shi

Eli Lilly and Company

United States

Engineering & Technology / Nanoscience and Nanotechnology

Drug Discovery

Informatics

Computational Chemistry

Biophysics

Nanotechnology

H-Index Rankings

University / Institution:

# 5

Country:

# 14,949

Region:

# 16,564

World:

# 35,734

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.831

i10 Index

Total:

204

Last 6 Year:

186

Last 6 Year/Total:

0.912

Citation

Total:

16,776

Last 6 Year:

11,173

Last 6 Year/Total:

0.666

Eswar Krishnan

Eli Lilly and Company

United States

Others

H-Index Rankings

University / Institution:

# 6

Country:

# 17,246

Region:

# 19,163

World:

# 42,076

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.629

i10 Index

Total:

104

Last 6 Year:

Last 6 Year/Total:

0.798

Citation

Total:

12,731

Last 6 Year:

4,821

Last 6 Year/Total:

0.379

Michael O'Neill

Eli Lilly and Company

United States

Others

Neurodegeneration

Neuroscience

H-Index Rankings

University / Institution:

# 7

Country:

# 18,252

Region:

# 20,287

World:

# 44,729

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.525

i10 Index

Total:

135

Last 6 Year:

Last 6 Year/Total:

0.548

Citation

Total:

10,811

Last 6 Year:

3,644

Last 6 Year/Total:

0.337

Martin Citron

Eli Lilly and Company

United States

Others

Alzheimer's disease

Neurodegeneration

Drug discovery

H-Index Rankings

University / Institution:

# 8

Country:

# 18,896

Region:

# 21,015

World:

# 46,476

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.617

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.744

Citation

Total:

35,642

Last 6 Year:

6,111

Last 6 Year/Total:

0.171

JH Krege

Eli Lilly and Company

United States

Others

Osteoporosis

Migraine

Cardiovascular Disease

Drug Development

H-Index Rankings

University / Institution:

# 9

Country:

# 23,406

Region:

# 26,149

World:

# 59,421

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.618

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.745

Citation

Total:

14,753

Last 6 Year:

3,706

Last 6 Year/Total:

0.251

Bob Campbell

Eli Lilly and Company

United States

Medical and Health Sciences / Medical Oncology

oncology/I-O/autoimmune diseases

drug discovery

kinases

epigenetics

RNA modulation

H-Index Rankings

University / Institution:

# 10

Country:

# 25,842

Region:

# 28,940

World:

# 66,684

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.491

i10 Index

Total:

112

Last 6 Year:

Last 6 Year/Total:

0.348

Citation

Total:

9,752

Last 6 Year:

3,220

Last 6 Year/Total:

0.330

Click for INSTITUTIONAL REGISTRATION and PREMIUM MEMBERSHIP advantages

Mark L Hartman

Eli Lilly and Company

United States

Medical and Health Sciences / Endocrinology and Metabolism

Diabetes

endocrinology

fatty liver disease

H-Index Rankings

University / Institution:

# 11

Country:

# 29,645

Region:

# 33,286

World:

# 78,235

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.440

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.534

Citation

Total:

9,758

Last 6 Year:

1,851

Last 6 Year/Total:

0.190

Francis Willard

Eli Lilly and Company

United States

Medical and Health Sciences / Pharmacology

Drug Discovery

G-proteins

GPCRs

Receptors

Pharmacology

H-Index Rankings

University / Institution:

# 12

Country:

# 31,987

Region:

# 35,957

World:

# 85,774

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.583

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.654

Citation

Total:

7,732

Last 6 Year:

2,593

Last 6 Year/Total:

0.335

Jonathan A Lee

Eli Lilly and Company

United States

Others

H-Index Rankings

University / Institution:

# 13

Country:

# 32,392

Region:

# 36,424

World:

# 86,954

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.375

i10 Index

Total:

141

Last 6 Year:

Last 6 Year/Total:

0.234

Citation

Total:

9,757

Last 6 Year:

2,425

Last 6 Year/Total:

0.249

Tony Zhang

Eli Lilly and Company

United States

Natural Sciences / Chemical Sciences

process chemistry

organic chemistry. pharmaceutical

green chemistry

catalysis

H-Index Rankings

University / Institution:

# 14

Country:

# 33,188

Region:

# 37,317

World:

# 89,637

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.638

i10 Index

Total:

143

Last 6 Year:

Last 6 Year/Total:

0.469

Citation

Total:

9,573

Last 6 Year:

3,992

Last 6 Year/Total:

0.417

Prachi Sharma

Eli Lilly and Company

United States

Medical and Health Sciences / Immunology

Immuno-Oncology

H-Index Rankings

University / Institution:

# 15

Country:

# 36,151

Region:

# 40,673

World:

# 99,004

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.689

i10 Index

Total:

207

Last 6 Year:

105

Last 6 Year/Total:

0.507

Citation

Total:

9,542

Last 6 Year:

5,069

Last 6 Year/Total:

0.531

Sreekumar Pillai

Eli Lilly and Company

United States

Natural Sciences / Molecular Biology & Genetics

Drug Discovery and Development

Precision Medicine

Digital Health

Genetics

Orphan diseases

H-Index Rankings

University / Institution:

# 16

Country:

# 38,031

Region:

# 42,848

World:

# 105,293

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.636

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.742

Citation

Total:

9,969

Last 6 Year:

3,293

Last 6 Year/Total:

0.330

Scot J Matkovich

Eli Lilly and Company

United States

Others

Heart disease

inflammation

diabetes

noncoding RNAs

systems biology

H-Index Rankings

University / Institution:

# 17

Country:

# 39,367

Region:

# 44,377

World:

# 109,527

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.744

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.792

Citation

Total:

7,313

Last 6 Year:

2,839

Last 6 Year/Total:

0.388

Giacomo Ruotolo

Eli Lilly and Company

United States

Others

Lipoprotein Metabolism and Atherosclerosis

H-Index Rankings

University / Institution:

# 18

Country:

# 39,849

Region:

# 44,940

World:

# 111,240

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.628

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.595

Citation

Total:

7,541

Last 6 Year:

2,461

Last 6 Year/Total:

0.326

Louis F Stancato

Eli Lilly and Company

United States

Others

Cancer

H-Index Rankings

University / Institution:

# 19

Country:

# 42,065

Region:

# 47,442

World:

# 118,540

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.548

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.578

Citation

Total:

6,071

Last 6 Year:

1,575

Last 6 Year/Total:

0.259

Joel Raskin

Eli Lilly and Company

United States

Social Sciences / Psychology

psychopharmamcology

H-Index Rankings

University / Institution:

# 20

Country:

# 42,144

Region:

# 47,536

World:

# 118,777

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.524

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.521

Citation

Total:

7,153

Last 6 Year:

2,220

Last 6 Year/Total:

0.310

José Antonio Sacristán

Eli Lilly and Company

United States

Others

Clinical research

patients

methodology

effectiveness

cost-effectiveness

H-Index Rankings

University / Institution:

# 21

Country:

# 44,159

Region:

# 49,853

World:

# 125,699

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.488

i10 Index

Total:

100

Last 6 Year:

Last 6 Year/Total:

0.380

Citation

Total:

6,540

Last 6 Year:

2,213

Last 6 Year/Total:

0.338

David H Adams

Eli Lilly and Company

United States

Others

H-Index Rankings

University / Institution:

# 22

Country:

# 45,591

Region:

# 51,474

World:

# 130,712

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.650

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.570

Citation

Total:

7,121

Last 6 Year:

3,525

Last 6 Year/Total:

0.495

Andrew C Adams

Eli Lilly and Company

United States

Others

RNA

Oligonucleotides

Delivery of Novel Modalities

Virology

SARS-CoV-2

H-Index Rankings

University / Institution:

# 23

Country:

# 46,930

Region:

# 52,992

World:

# 135,057

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.846

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.903

Citation

Total:

12,238

Last 6 Year:

8,305

Last 6 Year/Total:

0.679

Richard E Higgs

Eli Lilly and Company

United States

Natural Sciences / Mathematical Sciences

Statistics

Applied statistics in drug discovery

Translational research

H-Index Rankings

University / Institution:

# 24

Country:

# 48,172

Region:

# 54,432

World:

# 139,513

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.590

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.552

Citation

Total:

7,667

Last 6 Year:

4,512

Last 6 Year/Total:

0.588

Imre Pavo

Eli Lilly and Company

United States

Others

diabetes

cardiovascular diseases

osteoporosis

H-Index Rankings

University / Institution:

# 25

Country:

# 50,221

Region:

# 56,737

World:

# 146,625

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.632

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.576

Citation

Total:

5,526

Last 6 Year:

2,193

Last 6 Year/Total:

0.397

Stéphane Epelbaum

Eli Lilly and Company

United States

Medical and Health Sciences / Neuroscience

Alzheimer's disease

H-Index Rankings

University / Institution:

# 26

Country:

# 51,194

Region:

# 57,835

World:

# 149,928

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.946

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.963

Citation

Total:

10,645

Last 6 Year:

7,969

Last 6 Year/Total:

0.749

Klaus Gottlieb

Eli Lilly and Company

United States

Others

Clinical Trials

Inflammatory Bowel Disease

H-Index Rankings

University / Institution:

# 27

Country:

# 52,721

Region:

# 59,578

World:

# 155,711

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.622

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.545

Citation

Total:

5,400

Last 6 Year:

1,656

Last 6 Year/Total:

0.307

James W Perfield Ii

Eli Lilly and Company

United States

Others

H-Index Rankings

University / Institution:

# 28

Country:

# 57,925

Region:

# 65,505

World:

# 174,292

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.657

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.736

Citation

Total:

5,947

Last 6 Year:

1,907

Last 6 Year/Total:

0.321

Sudhakar Reddy Chintharlapalli

Eli Lilly and Company

United States

Medical and Health Sciences / Immunology

Immunooncology

Myeloid Biology

Angiogenesis

Oncology

Cancer Therapeutics

H-Index Rankings

University / Institution:

# 29

Country:

# 58,236

Region:

# 65,862

World:

# 175,490

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.600

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.709

Citation

Total:

5,566

Last 6 Year:

2,005

Last 6 Year/Total:

0.360

Rebecca L Robinson

Eli Lilly and Company

United States

Others

Health Outcomes

Real World Evidence

Pain

H-Index Rankings

University / Institution:

# 30

Country:

# 60,707

Region:

# 68,683

World:

# 184,414

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.676

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.750

Citation

Total:

9,969

Last 6 Year:

3,368

Last 6 Year/Total:

0.338

A New and Different Feature!!!! University Subject Rankings in 12 subjects:

Ranking and analysis of universities by subject in 12 fields such as health, engineering, natural sciences, education, business, economics, social sciences, etc.

Joe Johnston

Eli Lilly and Company

United States

Medical and Health Sciences / Pediatrics and Child Health

Health outcomes

pediatrics

epidemiology

H-Index Rankings

University / Institution:

# 31

Country:

# 60,988

Region:

# 69,007

World:

# 185,492

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.618

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.612

Citation

Total:

6,952

Last 6 Year:

3,036

Last 6 Year/Total:

0.437

Zvonko Milicevic

Eli Lilly and Company

United States

Others

Diabetes

H-Index Rankings

University / Institution:

# 32

Country:

# 62,960

Region:

# 71,225

World:

# 192,281

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.788

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.493

Citation

Total:

5,362

Last 6 Year:

2,987

Last 6 Year/Total:

0.557

J Michael Sauder

Eli Lilly and Company

United States

Natural Sciences / Biological Science

structural biology

computational biology

structural bioinformatics

biophysics

H-Index Rankings

University / Institution:

# 33

Country:

# 64,594

Region:

# 73,092

World:

# 198,395

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.545

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.482

Citation

Total:

6,281

Last 6 Year:

1,838

Last 6 Year/Total:

0.293

Yaming Wang

Eli Lilly and Company

United States

Others

innate immunity

neuroimmunology

neurodegneration

pathagen/damage associated molecular patterns

host-pathogen interaction

H-Index Rankings

University / Institution:

# 34

Country:

# 66,739

Region:

# 75,509

World:

# 205,850

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.750

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.879

Citation

Total:

9,910

Last 6 Year:

6,103

Last 6 Year/Total:

0.616

Ilya Lipkovich

Eli Lilly and Company

United States

Natural Sciences / Mathematical Sciences

Statistics

H-Index Rankings

University / Institution:

# 35

Country:

# 67,690

Region:

# 76,595

World:

# 209,674

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.594

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.683

Citation

Total:

3,155

Last 6 Year:

1,535

Last 6 Year/Total:

0.487

Howard Broughton

Eli Lilly and Company

United States

Natural Sciences / Chemical Sciences

Computational chemistry

molecular modeling

biophysics

H-Index Rankings

University / Institution:

# 36

Country:

# 68,340

Region:

# 77,343

World:

# 211,910

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.438

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.278

Citation

Total:

4,113

Last 6 Year:

735

Last 6 Year/Total:

0.179

David Cox

Eli Lilly and Company

United States

Others

H-Index Rankings

University / Institution:

# 37

Country:

# 68,382

Region:

# 77,389

World:

# 212,023

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.438

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.440

Citation

Total:

6,370

Last 6 Year:

853

Last 6 Year/Total:

0.134

Henning Stöckmann

Eli Lilly and Company

United States

Natural Sciences / Biological Science

Biotechnology

Drug Discovery

Chemical Biology

Glycobiology

H-Index Rankings

University / Institution:

# 38

Country:

# 70,005

Region:

# 79,232

World:

# 218,065

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.774

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.907

Citation

Total:

2,339

Last 6 Year:

1,403

Last 6 Year/Total:

0.600

Wei Shen

Eli Lilly and Company

United States

Natural Sciences / Mathematical Sciences

Statistics

clinical trials

health outcomes research

Bayesian methods

H-Index Rankings

University / Institution:

# 39

Country:

# 71,431

Region:

# 80,860

World:

# 223,670

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.581

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.550

Citation

Total:

4,592

Last 6 Year:

937

Last 6 Year/Total:

0.204

Olivier Benichou

Eli Lilly and Company

United States

Others

osteopetrosis

psoriatic arthritis

rheumatoid arthritis

muscle

osteoarthrtis

H-Index Rankings

University / Institution:

# 40

Country:

# 74,765

Region:

# 84,646

World:

# 236,344

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.633

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.675

Citation

Total:

4,064

Last 6 Year:

1,361

Last 6 Year/Total:

0.335

Michal Vieth

Eli Lilly and Company

United States

Natural Sciences / Chemical Sciences

cancer cure and business

power of brain

VR and AI

extreme sports psychology and sociology

H-Index Rankings

University / Institution:

# 41

Country:

# 75,129

Region:

# 85,059

World:

# 237,754

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.567

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.532

Citation

Total:

5,615

Last 6 Year:

1,470

Last 6 Year/Total:

0.262

Nalin Payakacha

Eli Lilly and Company

United States

Economics & Econometrics / Economics

Quality of life research

Patient-reported outcomes

Health economics

Cancer

H-Index Rankings

University / Institution:

# 42

Country:

# 76,715

Region:

# 86,838

World:

# 243,308

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.862

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.896

Citation

Total:

2,847

Last 6 Year:

2,099

Last 6 Year/Total:

0.737

Prashant Desai

Eli Lilly and Company

United States

Others

Drug discovery

H-Index Rankings

University / Institution:

# 43

Country:

# 78,558

Region:

# 88,932

World:

# 250,613

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.655

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.633

Citation

Total:

4,138

Last 6 Year:

1,263

Last 6 Year/Total:

0.305

Robert W Siegel

Eli Lilly and Company

United States

Others

H-Index Rankings

University / Institution:

# 44

Country:

# 79,236

Region:

# 89,710

World:

# 253,274

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.552

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.520

Citation

Total:

4,102

Last 6 Year:

1,758

Last 6 Year/Total:

0.429

Valentina Pirro

Eli Lilly and Company

United States

Natural Sciences / Chemical Sciences

Analytical Chemistry

Toxicology

Mass Spectrometry

Chemometrics

H-Index Rankings

University / Institution:

# 45

Country:

# 82,624

Region:

# 93,561

World:

# 266,214

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.679

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.857

Citation

Total:

2,373

Last 6 Year:

1,350

Last 6 Year/Total:

0.569

Ricardo Martinez

Eli Lilly and Company

United States

Medical and Health Sciences / Medical Oncology

Oncology

Genomics

Tailored Therapeutics

H-Index Rankings

University / Institution:

# 46

Country:

# 82,692

Region:

# 93,636

World:

# 266,385

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.679

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.639

Citation

Total:

19,235

Last 6 Year:

4,579

Last 6 Year/Total:

0.238

Ying Liu

Eli Lilly and Company

United States

Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Epidemiology

H-Index Rankings

University / Institution:

# 47

Country:

# 83,922

Region:

# 95,016

World:

# 271,150

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.429

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.382

Citation

Total:

3,045

Last 6 Year:

524

Last 6 Year/Total:

0.172

Min Jiang

Eli Lilly and Company

United States

Engineering & Technology / Computer Science

clinical Natural Language Processing

information extraction

predictive modeling

H-Index Rankings

University / Institution:

# 48

Country:

# 86,510

Region:

# 97,935

World:

# 281,220

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.741

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.889

Citation

Total:

3,088

Last 6 Year:

1,914

Last 6 Year/Total:

0.620

Matthew Coghlan

Eli Lilly and Company

United States

Others

Diabetes and Complications

H-Index Rankings

University / Institution:

# 49

Country:

# 87,241

Region:

# 98,771

World:

# 284,112

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.667

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.706

Citation

Total:

4,111

Last 6 Year:

1,440

Last 6 Year/Total:

0.350

Ian C Smith

Eli Lilly and Company

United States

Medical and Health Sciences / Medical Oncology

Oncology

H-Index Rankings

University / Institution:

# 50

Country:

# 87,730

Region:

# 99,341

World:

# 286,217

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.593

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.541

Citation

Total:

9,634

Last 6 Year:

4,531

Last 6 Year/Total:

0.470

				AD Scientific Index - World Scientists Rankings - 2024				H INDEX			i10 INDEX			CITATION
University / Institution	Country	Region	World	Name	Country	University / Institution	Subject	Total	Last 6 year	Last 6 year/total	Total	Last 6 year	Last 6 year/total	Total	Last 6 year	Last 6 year/total
1	1,804	1,940	3,860	David A Collier ⁱ	United States	Eli Lilly and Company	Social Sciences / Psychology psychosis \| neurodegeneration \| bioinformatics \| genomics \| drug development \|	122	62	0.508	436	247	0.567	80,727	27,588	0.342
2	9,841	10,820	22,504	Stephen Hall	United States	Eli Lilly and Company	Others PBPK Models \| DDI \| CYPs \|	76	36	0.474	174	105	0.603	22,555	4,677	0.207
3	10,275	11,296	23,566	Christian C Felder	United States	Eli Lilly and Company	Medical and Health Sciences / Neuroscience Neuroscience & Drug Discovery \|	75	33	0.440	141	86	0.610	24,931	4,992	0.200
4	11,020	12,132	25,527	David R Ferry	United States	Eli Lilly and Company	Others GI cancer \| translational research \| lung cancer \| phase 1 trials \|	73	40	0.548	175	84	0.480	26,276	8,585	0.327
5	14,949	16,564	35,734	Jiye Shi	United States	Eli Lilly and Company	Engineering & Technology / Nanoscience and Nanotechnology Drug Discovery \| Informatics \| Computational Chemistry \| Biophysics \| Nanotechnology \|	65	54	0.831	204	186	0.912	16,776	11,173	0.666
6	17,246	19,163	42,076	Eswar Krishnan	United States	Eli Lilly and Company	Others	62	39	0.629	104	83	0.798	12,731	4,821	0.379
7	18,252	20,287	44,729	Michael O'Neill	United States	Eli Lilly and Company	Others Neurodegeneration \| Neuroscience \|	61	32	0.525	135	74	0.548	10,811	3,644	0.337
8	18,896	21,015	46,476	Martin Citron	United States	Eli Lilly and Company	Others Alzheimer's disease \| Neurodegeneration \| Drug discovery \|	60	37	0.617	82	61	0.744	35,642	6,111	0.171
9	23,406	26,149	59,421	JH Krege	United States	Eli Lilly and Company	Others Osteoporosis \| Migraine \| Cardiovascular Disease \| Drug Development \|	55	34	0.618	98	73	0.745	14,753	3,706	0.251
10	25,842	28,940	66,684	Bob Campbell	United States	Eli Lilly and Company	Medical and Health Sciences / Medical Oncology oncology/I-O/autoimmune diseases \| drug discovery \| kinases \| epigenetics \| RNA modulation \|	53	26	0.491	112	39	0.348	9,752	3,220	0.330
			Click for INSTITUTIONAL REGISTRATION and PREMIUM MEMBERSHIP advantages
11	29,645	33,286	78,235	Mark L Hartman	United States	Eli Lilly and Company	Medical and Health Sciences / Endocrinology and Metabolism Diabetes \| endocrinology \| fatty liver disease \|	50	22	0.440	73	39	0.534	9,758	1,851	0.190
12	31,987	35,957	85,774	Francis Willard	United States	Eli Lilly and Company	Medical and Health Sciences / Pharmacology Drug Discovery \| G-proteins \| GPCRs \| Receptors \| Pharmacology \|	48	28	0.583	81	53	0.654	7,732	2,593	0.335
13	32,392	36,424	86,954	Jonathan A Lee	United States	Eli Lilly and Company	Others	48	18	0.375	141	33	0.234	9,757	2,425	0.249
14	33,188	37,317	89,637	Tony Zhang	United States	Eli Lilly and Company	Natural Sciences / Chemical Sciences process chemistry \| organic chemistry. pharmaceutical \| green chemistry \| catalysis \|	47	30	0.638	143	67	0.469	9,573	3,992	0.417
15	36,151	40,673	99,004	Prachi Sharma	United States	Eli Lilly and Company	Medical and Health Sciences / Immunology Immuno-Oncology \|	45	31	0.689	207	105	0.507	9,542	5,069	0.531
16	38,031	42,848	105,293	Sreekumar Pillai	United States	Eli Lilly and Company	Natural Sciences / Molecular Biology & Genetics Drug Discovery and Development \| Precision Medicine \| Digital Health \| Genetics \| Orphan diseases \|	44	28	0.636	66	49	0.742	9,969	3,293	0.330
17	39,367	44,377	109,527	Scot J Matkovich	United States	Eli Lilly and Company	Others Heart disease \| inflammation \| diabetes \| noncoding RNAs \| systems biology \|	43	32	0.744	72	57	0.792	7,313	2,839	0.388
18	39,849	44,940	111,240	Giacomo Ruotolo	United States	Eli Lilly and Company	Others Lipoprotein Metabolism and Atherosclerosis \|	43	27	0.628	74	44	0.595	7,541	2,461	0.326
19	42,065	47,442	118,540	Louis F Stancato	United States	Eli Lilly and Company	Others Cancer \|	42	23	0.548	64	37	0.578	6,071	1,575	0.259
20	42,144	47,536	118,777	Joel Raskin	United States	Eli Lilly and Company	Social Sciences / Psychology psychopharmamcology \|	42	22	0.524	73	38	0.521	7,153	2,220	0.310
21	44,159	49,853	125,699	José Antonio Sacristán	United States	Eli Lilly and Company	Others Clinical research \| patients \| methodology \| effectiveness \| cost-effectiveness \|	41	20	0.488	100	38	0.380	6,540	2,213	0.338
22	45,591	51,474	130,712	David H Adams	United States	Eli Lilly and Company	Others	40	26	0.650	86	49	0.570	7,121	3,525	0.495
23	46,930	52,992	135,057	Andrew C Adams	United States	Eli Lilly and Company	Others RNA \| Oligonucleotides \| Delivery of Novel Modalities \| Virology \| SARS-CoV-2 \|	39	33	0.846	62	56	0.903	12,238	8,305	0.679
24	48,172	54,432	139,513	Richard E Higgs	United States	Eli Lilly and Company	Natural Sciences / Mathematical Sciences Statistics \| Applied statistics in drug discovery \| Translational research \|	39	23	0.590	67	37	0.552	7,667	4,512	0.588
25	50,221	56,737	146,625	Imre Pavo	United States	Eli Lilly and Company	Others diabetes \| cardiovascular diseases \| osteoporosis \|	38	24	0.632	85	49	0.576	5,526	2,193	0.397
26	51,194	57,835	149,928	Stéphane Epelbaum	United States	Eli Lilly and Company	Medical and Health Sciences / Neuroscience Alzheimer's disease \|	37	35	0.946	82	79	0.963	10,645	7,969	0.749
27	52,721	59,578	155,711	Klaus Gottlieb	United States	Eli Lilly and Company	Others Clinical Trials \| Inflammatory Bowel Disease \|	37	23	0.622	66	36	0.545	5,400	1,656	0.307
28	57,925	65,505	174,292	James W Perfield Ii	United States	Eli Lilly and Company	Others	35	23	0.657	53	39	0.736	5,947	1,907	0.321
29	58,236	65,862	175,490	Sudhakar Reddy Chintharlapalli	United States	Eli Lilly and Company	Medical and Health Sciences / Immunology Immunooncology \| Myeloid Biology \| Angiogenesis \| Oncology \| Cancer Therapeutics \|	35	21	0.600	55	39	0.709	5,566	2,005	0.360
30	60,707	68,683	184,414	Rebecca L Robinson	United States	Eli Lilly and Company	Others Health Outcomes \| Real World Evidence \| Pain \|	34	23	0.676	52	39	0.750	9,969	3,368	0.338
			A New and Different Feature!!!! University Subject Rankings in 12 subjects: Ranking and analysis of universities by subject in 12 fields such as health, engineering, natural sciences, education, business, economics, social sciences, etc.
31	60,988	69,007	185,492	Joe Johnston	United States	Eli Lilly and Company	Medical and Health Sciences / Pediatrics and Child Health Health outcomes \| pediatrics \| epidemiology \|	34	21	0.618	67	41	0.612	6,952	3,036	0.437
32	62,960	71,225	192,281	Zvonko Milicevic	United States	Eli Lilly and Company	Others Diabetes \|	33	26	0.788	67	33	0.493	5,362	2,987	0.557
33	64,594	73,092	198,395	J Michael Sauder	United States	Eli Lilly and Company	Natural Sciences / Biological Science structural biology \| computational biology \| structural bioinformatics \| biophysics \|	33	18	0.545	56	27	0.482	6,281	1,838	0.293
34	66,739	75,509	205,850	Yaming Wang	United States	Eli Lilly and Company	Others innate immunity \| neuroimmunology \| neurodegneration \| pathagen/damage associated molecular patterns \| host-pathogen interaction \|	32	24	0.750	33	29	0.879	9,910	6,103	0.616
35	67,690	76,595	209,674	Ilya Lipkovich	United States	Eli Lilly and Company	Natural Sciences / Mathematical Sciences Statistics \|	32	19	0.594	60	41	0.683	3,155	1,535	0.487
36	68,340	77,343	211,910	Howard Broughton	United States	Eli Lilly and Company	Natural Sciences / Chemical Sciences Computational chemistry \| molecular modeling \| biophysics \|	32	14	0.438	72	20	0.278	4,113	735	0.179
37	68,382	77,389	212,023	David Cox	United States	Eli Lilly and Company	Others	32	14	0.438	50	22	0.440	6,370	853	0.134
38	70,005	79,232	218,065	Henning Stöckmann	United States	Eli Lilly and Company	Natural Sciences / Biological Science Biotechnology \| Drug Discovery \| Chemical Biology \| Glycobiology \|	31	24	0.774	43	39	0.907	2,339	1,403	0.600
39	71,431	80,860	223,670	Wei Shen	United States	Eli Lilly and Company	Natural Sciences / Mathematical Sciences Statistics \| clinical trials \| health outcomes research \| Bayesian methods \|	31	18	0.581	40	22	0.550	4,592	937	0.204
40	74,765	84,646	236,344	Olivier Benichou	United States	Eli Lilly and Company	Others osteopetrosis \| psoriatic arthritis \| rheumatoid arthritis \| muscle \| osteoarthrtis \|	30	19	0.633	40	27	0.675	4,064	1,361	0.335
41	75,129	85,059	237,754	Michal Vieth	United States	Eli Lilly and Company	Natural Sciences / Chemical Sciences cancer cure and business \| power of brain \| VR and AI \| extreme sports psychology and sociology \|	30	17	0.567	47	25	0.532	5,615	1,470	0.262
42	76,715	86,838	243,308	Nalin Payakacha	United States	Eli Lilly and Company	Economics & Econometrics / Economics Quality of life research \| Patient-reported outcomes \| Health economics \| Cancer \|	29	25	0.862	48	43	0.896	2,847	2,099	0.737
43	78,558	88,932	250,613	Prashant Desai	United States	Eli Lilly and Company	Others Drug discovery \|	29	19	0.655	49	31	0.633	4,138	1,263	0.305
44	79,236	89,710	253,274	Robert W Siegel	United States	Eli Lilly and Company	Others	29	16	0.552	50	26	0.520	4,102	1,758	0.429
45	82,624	93,561	266,214	Valentina Pirro	United States	Eli Lilly and Company	Natural Sciences / Chemical Sciences Analytical Chemistry \| Toxicology \| Mass Spectrometry \| Chemometrics \|	28	19	0.679	42	36	0.857	2,373	1,350	0.569
46	82,692	93,636	266,385	Ricardo Martinez	United States	Eli Lilly and Company	Medical and Health Sciences / Medical Oncology Oncology \| Genomics \| Tailored Therapeutics \|	28	19	0.679	36	23	0.639	19,235	4,579	0.238
47	83,922	95,016	271,150	Ying Liu	United States	Eli Lilly and Company	Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences Epidemiology \|	28	12	0.429	34	13	0.382	3,045	524	0.172
48	86,510	97,935	281,220	Min Jiang	United States	Eli Lilly and Company	Engineering & Technology / Computer Science clinical Natural Language Processing \| information extraction \| predictive modeling \|	27	20	0.741	36	32	0.889	3,088	1,914	0.620
49	87,241	98,771	284,112	Matthew Coghlan	United States	Eli Lilly and Company	Others Diabetes and Complications \|	27	18	0.667	34	24	0.706	4,111	1,440	0.350
50	87,730	99,341	286,217	Ian C Smith	United States	Eli Lilly and Company	Medical and Health Sciences / Medical Oncology Oncology \|	27	16	0.593	37	20	0.541	9,634	4,531	0.470